Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

2.77
-0.2200-7.36%
Post-market: 2.770.00000.00%16:10 EDT
Volume:1.58M
Turnover:4.44M
Market Cap:315.78M
PE:-2.08
High:3.01
Open:2.96
Low:2.75
Close:2.99
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.88M
Volume Ratio:1.38
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:0.98
PE(LYR):-1.98

Loading ...

Perspective Therapeutics Updates Radiopharmaceutical Oncology Pipeline Outlook

TIPRANKS
·
Sep 09

Lantheus Alpha Therapy Disposes of USD 773,930 in Perspective Therapeutics Common Shares

Reuters
·
Sep 09

Lantheus Alpha Therapy Disposes of USD 358,084 Perspective Therapeutics Common Shares

Reuters
·
Sep 05

Lantheus Holdings Reports Sale of 78,145 Perspective Therapeutics Shares Worth $245,641

Reuters
·
Sep 03

BMO Capital Initiates Perspective Therapeutics at Outperform

MT Newswires Live
·
Aug 19

Perspective Therapeutics is Maintained at Neutral by B of a Securities

Dow Jones
·
Aug 15

BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6

MT Newswires Live
·
Aug 14

RBC Capital Sticks to Their Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
Aug 12

Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says

MT Newswires Live
·
Aug 11

Wedbush Sticks to Their Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
Aug 11

Perspective Therapeutics (CATX) Receives a Buy from Truist Financial

TIPRANKS
·
Aug 11

Perspective Therapeutics price target lowered to $14 from $16 at Piper Sandler

TIPRANKS
·
Aug 11

Perspective Therapeutics Q2 EPS $(0.22) Beats $(0.26) Estimate, Sales $81.000K Miss $83.154K Estimate

Benzinga Earnings
·
Aug 11

Perspective Therapeutics Q2 EPS USD -0.22

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 11

Perspective Therapeutics Q2 Net Income from Cont Ops USD -26.983 Million

THOMSON REUTERS
·
Aug 11

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results

THOMSON REUTERS
·
Aug 11

Perspective Therapeutics Advances 212Pb Radiopharmaceutical Oncology Platform

TIPRANKS
·
Aug 04

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 31

Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation

MT Newswires Live
·
Jul 28